Test for p53 Needed to Prescreen Blood Cancer Patients (IMAGE)
Caption
Death of tumor cells after treatment with protease inhibitors (green). Left, tumor lacking p53, with only fraction of cells killed. Right, tumor producing p53, with massive cell death.
Credit
Andrei Thomas-Tikhonenko, PhD, University of Pennsylvania; Blood
Usage Restrictions
None
License
Licensed content